Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi, Gilead said to be eyeing potential $10B deal for prime cancer target Tesaro
Sanofi, Gilead said to be eyeing potential $10B deal for prime cancer target Tesaro
Sanofi, Gilead said to be eyeing potential $10B deal for prime cancer target Tesaro
Submitted by
admin
on June 12, 2017 - 9:40pm
Source:
Fierce Pharma
News Tags:
Sanofi
Gilead Sciences
Tesaro
M&A
Headline:
Sanofi, Gilead said to be eyeing potential $10B deal for prime cancer target Tesaro
Do Not Allow Advertisers to Use My Personal information
